Neuro-Oncological Diseases Device Market

Neuro-oncological diseases are the disorders that are typically caused due to the growth of a benign or malignant tumor in the brain or any part of the central nervous system. Neuro-oncological tumors are highly fatal, and so their diagnosis becomes a topic of foremost importance. There are a number of neuro-oncological diagnosis devices based on a variety of techniques for the diagnosis of neuro-oncological diseases.

Neuro-Oncological Diseases Device Market contains market size and forecasts of Neuro-Oncological Diseases Device in global, including the following market information:

• Global Neuro-Oncological Diseases Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Neuro-Oncological Diseases Device Market Sales, 2017-2022, 2023-2028, (Units)
• Global top five Neuro-Oncological Diseases Device companies in 2021 (%)

The global Neuro-Oncological Diseases Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

MRI Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neuro-Oncological Diseases Device include Siemens Healthcare, Philips Healthcare, Canon Medical Systems, GE Healthcare and Hitachi Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Neuro-Oncological Diseases Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neuro-Oncological Diseases Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Neuro-Oncological Diseases Device Market Segment Percentages, by Type, 2021 (%)

• MRI
• CT Scan
• PET
• Others

Global Neuro-Oncological Diseases Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Neuro-Oncological Diseases Device Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Diagnostics Centers
• Reference Laboratories
• Medical Research Institutes
• Others

Global Neuro-Oncological Diseases Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Neuro-Oncological Diseases Device Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Neuro-Oncological Diseases Device revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Neuro-Oncological Diseases Device revenues share in global market, 2021 (%)
• Key companies Neuro-Oncological Diseases Device sales in global market, 2017-2022 (Estimated), (Units)
• Key companies Neuro-Oncological Diseases Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Siemens Healthcare
• Philips Healthcare
• Canon Medical Systems
• GE Healthcare
• Hitachi Medical